BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10854838)

  • 1. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2000 Jun; 398(2):259-62. PubMed ID: 10854838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization.
    Szumlinski KK; McCafferty CA; Maisonneuve IM; Glick SD
    Brain Res; 2000 Jul; 871(2):245-58. PubMed ID: 10899291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.
    Maisonneuve IM; Keller RW; Glick SD
    Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies.
    Broderick PA; Phelan FT; Eng F; Wechsler RT
    Pharmacol Biochem Behav; 1994 Nov; 49(3):711-28. PubMed ID: 7862728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.
    Maisonneuve IM; Glick SD
    Eur J Pharmacol; 1992 Mar; 212(2-3):263-6. PubMed ID: 1601069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.
    Pearl SM; Maisonneuve IM; Glick SD
    Neuropharmacology; 1996; 35(12):1779-84. PubMed ID: 9076757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of electrophysiological method to study interactions between ibogaine and cocaine.
    Binienda Z; Beaudoin MA; Thorn BT; Sadovova N; Skinner RD; Slikker W; Ali SF
    Ann N Y Acad Sci; 2000 Sep; 914():387-93. PubMed ID: 11085337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Nov; 847(1):139-42. PubMed ID: 10564747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
    Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
    Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacological characterization of local ibogaine effects on dopamine release.
    Reid MS; Hsu K; Souza KH; Broderick PA; Berger SP
    J Neural Transm (Vienna); 1996; 103(8-9):967-85. PubMed ID: 9013390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.
    Glick SD; Maisonneuve IM; Visker KE; Fritz KA; Bandarage UK; Kuehne ME
    Psychopharmacology (Berl); 1998 Oct; 139(3):274-80. PubMed ID: 9784085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens.
    Kalivas PW; Duffy P
    Synapse; 1990; 5(1):48-58. PubMed ID: 2300906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core.
    Jocham G; Lezoch K; Müller CP; Kart-Teke E; Huston JP; de Souza Silva MA
    Eur J Neurosci; 2006 Sep; 24(6):1721-32. PubMed ID: 17004936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased accumbens dopamine release after cocaine challenge in behaviorally sensitized female rats.
    Johnson DW; Eodice P; Winterbottom H; Mokler DJ
    Pharmacol Biochem Behav; 2000 Apr; 65(4):659-64. PubMed ID: 10764919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
    Sershen H; Harsing LG; Hashim A; Lajtha A
    Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 1999 Jul; 145(2):227-33. PubMed ID: 10463325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine.
    Fontana DJ; Post RM; Pert A
    Brain Res; 1993 Nov; 629(1):31-9. PubMed ID: 8287278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychostimulant sensitization: differential changes in accumbal shell and core dopamine.
    Cadoni C; Solinas M; Di Chiara G
    Eur J Pharmacol; 2000 Jan; 388(1):69-76. PubMed ID: 10657548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
    Jocham G; Lauber AC; Müller CP; Huston JP; de Souza Silva MA
    Eur J Neurosci; 2007 Apr; 25(8):2457-72. PubMed ID: 17445241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.